ArchiMed, European private equity healthcare specialist, announces full digitalisation of its portfolio company, Italian dental clinics company Primo.
The digital transformation undertaken by Primo has enabled the company to upgrade to a modern, efficient and professional network of dental clinics and to a cutting edge innovative laboratory. Primo’s technological shift clearly aims at maintaining a high level patient service across all 42 clinics and at modernising its prosthetics workflow. Focusing on quality, technology and a relationship of trust, Primo reaffirms consequently its unique patient-driven positioning on the Italian dental market.
Primo Up, a unique dental software to lead the digital revolution of the clinics
The massive digital transformation has been led by the development of a unique dental software – Primo Up – to meet specific digitalisation requirements. Since December 2018, all clinics have switched to the web based Primo Up software leading to a 40% reduction of paper consumption.
The following online and cross clinic key functionalities have been implemented in all 42 clinics of the network:
- Access and management of dentists’ agendas;
- Access to patients’ records;
- Full clinic administrative management and approval process;
- Centralized quality control of patients’ treatments by pool of referent doctors;
- Dental panoramic radios archiving.
A dental laboratory at the cutting edge of innovation
Primo Lab, Primo’s central prosthetics laboratory opened in 2013, processes all prosthetics, guaranteeing homogenous quality across all clinics, has also undergone some major enhancements with the installation of the following equipment:
- Scanners and automatic milling machines;
- Computer-Aided Design (CAD) and Computer-Aided Manufacturing (CAM) Process of Prosthesis;
- With 70-80% of prosthesis processed digitally, quality, precision and turnaround time have significantly increased whereas the production time has been reduced to 1 or 2 days.
A sustained and controlled growth
Primo pursues its national expansion leveraging on strong founding values – high quality patients service, reasonable and sustainable pricing, long-term patient/dentist relationship, – and on key technological innovation.
About ArchiMed – www.archimed-group.eu – ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.
ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large size healthcare companies throughout the world, with a combined value above five billion euros.
ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.